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Notes from the Field
Underreporting of Maternal Hepatitis C Virus 
Infection Status and the Need for Infant 
Testing — Oregon, 2015
Stephanie D. Snodgrass, MPH1,2; Tasha M. Poissant, MPH2; 
Ann R. Thomas, MD2
The rate of deliveries to women with hepatitis C virus (HCV) 
infection has increased sharply in the United States (1). A 
review of 2009–2014 birth certificate data from 47 states that 
report HCV status of the mother on infant birth certificates 
found an 89% increase in prevalence of maternal HCV infec-
tion, from 1.8 per 1,000 live births in 2009 to 3.4 in 2014 (2). 
During the same period in Oregon, the prevalence of births 
to women with HCV infection increased 33%, from 2.91 per 
1,000 live births in 2009 to 3.87 in 2014. Although North 
American Society for Pediatric Gastroenterology, Hepatology, 
and Nutrition guidelines recommending testing of infants born 
to HCV-infected mothers at age 18 months were published 
in 2012 (3), a recent study conducted by the Philadelphia 
Department of Health found that only 16% of infants born 
to HCV-infected mothers in Philadelphia during 2011–2013 
had been appropriately tested (4). To evaluate the complete-
ness of reporting of maternal HCV infection in the state, the 
Oregon Health Authority compared birth certificate data with 
data reported to the state’s Acute and Communicable Disease 
Prevention (ACDP) program. The results of that comparison 
suggested that use of birth certificate data to identify infants 
born to women with HCV infection underestimates the 
prevalence of maternal HCV infection and that the majority of 
exposed infants did not receive age-appropriate HCV testing.
The following two data sources were used in the Oregon 
analysis: 1) female HCV cases reported to ACDP during 
2001–2015 and 2) Oregon birth certificate records from all live 
births in 2015, which included maternal HCV status. Using 
a probabilistic record linkage program for registry database 
linkage, ACDP surveillance records for HCV-positive women 
aged 15–50 years in 2015 were matched with mothers’ names 
and dates of birth from all live births in Oregon. The study 
was considered public health practice under Oregon statute 
and did not require review by the Oregon Health Authority’s 
public health institutional review board.
Among women with a positive HCV laboratory result 
reported to ACDP during 2001–2015, a total of 13,058 were 
aged 15–50 years in 2015. Among 44,712 women who had 
a live birth in 2015, maternal HCV infection was recorded 
on the birth certificates of 181 (0.4%) infants. Among these 
women, 150 (82.9%) were matched by name and date of birth 
to women with a positive HCV laboratory result reported to 
ACDP; 31 (17.1%) of the 181 women identified in birth 
certificates had not been reported to ACDP during the period 
2001–2015 (Table). An additional 113 women with a positive 
HCV laboratory result reported to ACDP matched women 
who had a live birth during 2015 but did not have a diagnosis 
of maternal HCV infection recorded on the birth certificate. 
Thus, the linkage resulted in identification of 294 women 
with HCV infection who gave birth in 2015, a 62% increase 
over the estimate of 181 women using birth certificates alone.
Assuming an estimated 5.8% rate of perinatal HCV trans-
mission (5), 17 of the 294 exposed infants would be expected 
to have acquired HCV infection. As of July 31, 2017 (at 
which time all children born in 2015 would have reached age 
18 months, the recommended age for testing children born 
to HCV-infected mothers), the ACDP database had recorded 
five positive HCV reports from infants born in 2015. Negative 
HCV tests are not reportable in Oregon, so it is unknown 
how many of the exposed infants were appropriately tested. 
However, the discrepancy between the number of reported 
positive results and the expected number based on estimates 
of perinatal transmission suggests that as many as 12 infants 
with HCV might not have been tested by age 18 months.
This investigation suggests that the use of birth certificate 
data to identify infants born to women with HCV infection 
underestimates the prevalence of maternal HCV infection 
and that the majority of exposed infants do not receive age-
appropriate HCV testing. New public health strategies are 
needed to actively identify infants at risk for HCV infection 
and ensure that they are tested appropriately.
TABLE. Comparison of women identified with hepatitis C virus (HCV) 
infection on infant’s birth certificates in 2015 with female HCV cases 
reported to the ACDP program — Oregon, 2001–2015
Laboratory diagnosis 
of HCV infection 
reported to ACDP
Maternal HCV infection recorded on infant’s 
birth certificate
Yes No Total
Yes 150 113 263
No 31 — 31
Total 181 113 294
Abbreviation: ACDP = Acute and Communicable Disease Prevention.
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